Psychiatry Research: Neuroimaging
Volume 146, Issue 2 , Pages 107-116 , 31 March 2006

Mood changes correlate to changes in brain serotonin precursor trapping in women with premenstrual dysphoria

  • Olle Eriksson

      Affiliations

    • Department of Women's and Children's Health/Obstetrics and Gynecology, University Hospital, SE-751 85 Uppsala, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46 18 6115777; fax: +46 18 559775.
    • ,
  • Anders Wall

      Affiliations

    • Uppsala Imanet AB, University Hospital, SE-751 85 Uppsala, Sweden
    • ,
  • Ina Marteinsdottir

      Affiliations

    • Department of Neuroscience, Section of Psychiatry, University Hospital, SE-751 85 Uppsala, Sweden
    • ,
  • Hans Ågren

      Affiliations

    • Neurotec Department, Division of Psychiatry, Karolinska Institute, SE-171 76 Stockholm, Sweden
    • ,
  • Per Hartvig

      Affiliations

    • Hospital Pharmacy, University Hospital, SE-751 85 Uppsala, Sweden
    • ,
  • Gunnar Blomqvist

      Affiliations

    • Uppsala Imanet AB, University Hospital, SE-751 85 Uppsala, Sweden
    • ,
  • Bengt Långström

      Affiliations

    • Uppsala Imanet AB, University Hospital, SE-751 85 Uppsala, Sweden
    • ,
  • Tord Naessén

      Affiliations

    • Department of Women's and Children's Health/Obstetrics and Gynecology, University Hospital, SE-751 85 Uppsala, Sweden

Received 27 July 2004 ,Revised 20 December 2004 ,Accepted 14 February 2005.

References 

  1. Ågren H, Reibring L. PET studies of presynaptic monoamine metabolism in depressed patients and healthy volunteers. Pharmacopsychiatry. 1994;27(1):2–6
  2. Ågren H, Reibring L, Hartvig P, Tedroff J, Bjurling P, Hörnfeldt K, et al. Low brain uptake of l-11C-5-hydroxytryptophan in major depression: a positron emission tomography study on patients and healthy volunteers. Acta Psychiatrica Scandinavica. 1991;83:449–455
  3. American Psychiatric Association . DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: APA; 1994;
  4. Andersson JLR. A rapid and accurate method to realign PET scans utilizing image edge transformation. Journal of Nuclear Medicine. 1995;36:657–669
  5. Arancibia S, Rage F, Astier H, Tapia-Arancibia L. Neuroendocrine and autonomous mechanisms underlying thermoregulation in cold environment. Neuroendocrinology. 1996;64(4):257–267
  6. Bjurling P, Watanabe Y, Tokushige M, Oda T, Långström B. Synthesis of beta-II-l-tryptophan and 5-hydroxy-l-tryptophan using a multi-enzymatic reaction route. Journal of the Chemical Society. Perkin Transactions 1. 1989;(1):1331–1334
  7. Bjurling P, Antoni G, Watanabe Y, Långström B. Enzymatic synthesis of carboxy-carbon-11-labelled l-tyrosine, l-DOPA, l-tryptophan and 5-hydroxy-l-tryptophan. Acta Chemica Scandinavica. 1990;44(2):178–182
  8. Brody AL, Barsom MW, Bota RG, Saxena S. Prefrontal-subcortical and limbic circuit mediation of major depressive disorder. Seminars in Clinical Neuropsychiatry. 2001;6(2):102–112
  9. Bruck A, Portin R, Lindell A, Laihinen A, Bergman J, Haaparanta M, et al. Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus. Neuroscience Letters. 2001;311(2):81–84
  10. Brzezinski AA, Wurtman JJ, Wurtman RJ, Gleason R, Greenfield J, Nader T. d-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of women with premenstrual depression. Obstetrics and Gynecology. 1990;76(2):296–301
  11. Bucht G, Adolfsson R, Gottfries CG, Roos BE, Winblad B. Distribution of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in human brain in relation to age, drug influence, agonal status and circadian variation. Journal of Neural Transmission. General Section. 1981;51(3–4):185–203
  12. Castellanos FX, Giedd JN, Eckburg P, Marsh WL, Vaituzis AC, Kaysen D, et al. Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder. American Journal of Psychiatry. 1994;151(12):1791–1796
  13. Churchill GA, Doerge RW. Empirical threshold values for quantitative trait mapping. Genetics. 1994;138:963–971
  14. Cohen LS, Miner C, Brown EW, Freeman E, Halbreich U, Sundell K, et al. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries. Obstetrics and Gynecology. 2002;100(3):435–444
  15. Davidson RJ. Anxiety and affective style: role of prefrontal cortex and amygdala. Biological Psychiatry. 2002;51(1):68–80
  16. Dimmock PW, Wyatt KM, Jones PW, O'Brien PM. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet. 2000;356(9236):1131–1136
  17. Dye L, Blundell JE. Menstrual cycle and appetite control: implications for weight regulation. Human Reproduction. 1997;12(6):1142–1151
  18. Eaton MJ, Gudehithlu KP, Quach T, Silvia CP, Hadjiconstantinou M, Neff NH. Distribution of aromatic l-amino acid decarboxylase mRNA in mouse brain by in situ hybridization histology. Journal of Comparative Neurology. 1993;337(4):640–654
  19. Eriksson E. Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria. International Clinical Psychopharmacology. 1999;14(Suppl 2):S27–S33
  20. Eriksson E, Hedberg MA, Andersch B, Sundblad C. The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology. 1995;12(2):167–176
  21. Eriksson E, Andersch B, Ho HP, Landen M, Sundblad C. Diagnosis and treatment of premenstrual dysphoria. Journal of Clinical Psychiatry. 2002;63(Suppl. 7):16–23
  22. Fernstrom JD. Tryptophan, serotonin and carbohydrate appetite: will the real carbohydrate craver please stand up!. Journal of Nutrition. 1988;118(11):1417–1419
  23. Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science. 1972;178(59):414–416
  24. In:  First MB,  Spitzer RL,  Gibbon M,  Williams JB,  Benjamin L editor. Structured Clinical Interview for DSM-IV. New York: New York State Psychiatric Institute; 1995;
  25. Greitz T, Bohm C, Holte S, Eriksson L. A computerized brain atlas: construction, anatomical content, and some applications. Journal of Computer Assisted Tomography. 1991;15:26–38
  26. Hagberg GE, Torstensson R, Marteinsdottir I, Fredriksson M, Langstrom B, Blomquist G. Kinetic compartment modelling of [11C]-5-hydroxy-l-tryptophan for PET assessment of serotonin synthesis in human brain. Journal of Cerebral Blood Flow and Metabolism. 2002;22(11):1352–1366
  27. Hammarbäck S, Bäckström T, MacGibbon-Taylor B. Diagnosis of premenstrual tension syndrome: description and evaluation of a procedure for diagnosis and differential diagnosis. Journal of Psychosomatic Obstetrics and Gynaecology. 1989;10:25–42
  28. Hartvig P, Lindner KJ, Tedroff J, Andersson Y, Bjurling P, Langstrom B. Brain kinetics of 11C-labelled l-tryptophan and 5-hydroxy-l-tryptophan in the rhesus monkey. A study using positron emission tomography. Journal of Neural Transmission. General Section. 1992;88(1):1–10
  29. Hartvig P, Tedroff J, Lindner KJ, Bjurling P, Chang CW, Tsukada H, et al. Positron emission tomographic studies on aromatic l-amino acid decarboxylase activity in vivo for l-DOPA and 5-hydroxy-l-tryptophan in the monkey brain. Journal of Neural Transmission. General Section. 1993;94(2):127–135
  30. Hokfelt T, Fuxe K, Goldstein M. Immunohistochemical localization of aromatic l-amino acid decarboxylase (DOPA decarboxylase) in central dopamine and 5-hydroxytryptamine nerve cell bodies of the rat. Brain Research. 1973;53(1):175–180
  31. Holte S, Eriksson L, Dahlbom M. A preliminary evaluation of the Scanditronix PC2048-15B brain scanner. European Journal of Nuclear Medicine. 1989;15(11):719–721
  32. Ifthikharuddin SF, Shrier DA, Numaguchi Y, Tang X, Ning R, Shibata DK, et al. MR volumetric analysis of the human basal ganglia: normative data. Academic Radiology. 2000;7(8):627–634
  33. Jacobs BL, Fornal CA. Serotonin and motor activity. Current Opinion in Neurobiology. 1997;7(6):820–825
  34. Jaeger C, Teitelman G, Joh T, Albert V, Park D, Reis D. Some neurones of the rat central nervous system contain aromatic-l-amino-acid decarboxylase but not monoamines. Science. 1983;219(4589):1233–1235
  35. Kaya GC, Pekcanlar A, Bekis R, Ada E, Miral S, Emiroglu N, et al. Technetium-99m HMPAO brain SPECT in children with attention deficit hyperactivity disorder. Annals of Nuclear Medicine. 2002;16(8):527–531
  36. Landen M, Eriksson O, Sundblad C, Andersch B, Naessen T, Eriksson E. Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo. Psychopharmacology. 2001;155(3):292–298
  37. Lindner KJ, Hartvig P, Bjurling P, Fasth KJ, Westerberg G, Langstrom B. Determination of 5-hydroxy-l-[beta-11C]tryptophan and its in vivo-formed radiolabeled metabolites in brain tissue using high performance liquid chromatography: a study supporting radiotracer kinetics obtained with positron emission tomography. Nuclear Medicine and Biology. 1997;24(8):733–738
  38. Lloyd KG, Hornykiewicz O. Occurrence and distribution of aromatic l-amino acid (l-DOPA) decarboxylase in the human brain. Journal of Neurochemistry. 1972;19(6):1549–1559
  39. Mackay AV, Davies P, Dewar AJ, Yates CM. Regional distribution of enzymes associated with neurotransmission by monoamines, acetylcholine and GABA in the human brain. Journal of Neurochemistry. 1978;30(4):827–839
  40. Menkes DB, Coates DC, Fawcett JP. Acute tryptophan depletion aggravates premenstrual syndrome. Journal of Affective Disorders. 1994;32(1):37–44
  41. Mountz JM, Bradley LA, Modell JG, Alexander RW, Triana-Alexander M, Aaron LA, et al. Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis and Rheumatism. 1995;38(7):926–938
  42. Nagatsu T, Yamamoto T, Kato T. A new and highly sensitive voltammetric assay for aromatic l-amino acid decarboxylase activity by high-performance liquid chromatography. Analytical Biochemistry. 1979;100(1):160–165
  43. Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C, et al. Differences between males and females in rates of serotonin synthesis in human brain. Proceedings of the National Academy of Sciences of the United States of America. 1997;94(10):5308–5313
  44. Parry BL. The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications. CNS Drugs. 2001;15(4):277–285
  45. Partonen T, Lonnqvist J. Seasonal affective disorder. Lancet. 1998;352(9137):1369–1374
  46. Rapkin A. A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder. Psychoneuroendocrinology. 2003;28(Suppl. 3):39–53
  47. Rehman HU, Masson EA. Neuroendocrinology of ageing. Age and Ageing. 2001;30(4):279–287
  48. Robbins TW. From arousal to cognition: the integrative position of the prefrontal cortex. Progress in Brain Research. 2000;126:469–483
  49. Rousset OG, Deep P, Kuwabara H, Evans AC, Gjedde AH, Cumming P. Effect of partial volume correction on estimates of the influx and cerebral metabolism of 6-[18F]fluoro-l-DOPA studied with PET in normal control and Parkinson's disease subjects. Synapse. 2000;37(2):81–89
  50. Stefanatos GA, Wasserstein J. Attention deficit/hyperactivity disorder as a right hemisphere syndrome. Selective literature review and detailed neuropsychological case studies. Annals of the New York Academy of Sciences. 2001;931:172–195
  51. Steinberg S, Annable L, Young SN, Belanger MC. Tryptophan in the treatment of late luteal phase dysphoric disorder: a pilot study. Journal of Psychiatry & Neuroscience. 1994;19(2):114–119
  52. Steiner M, Pearlstein T. Premenstrual dysphoria and the serotonin system: pathophysiology and treatment. Journal of Clinical Psychiatry. 2000;61(Suppl. 12):17–21
  53. Steiner M, Steinberg S, Stewart D, Carter D, Berger C, Reid R, et al. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. New England Journal of Medicine. 1995;332(23):1529–1534
  54. Steiner M, Romano SJ, Babcock S, Dillon J, Shuler C, Berger C, et al. The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder. British Journal of Obstetrics and Gynaecology. 2001;108(5):462–468
  55. Su TP, Schmidt PJ, Danaceau M, Murphy DL, Rubinow DR. Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls. Journal of Clinical Endocrinology and Metabolism. 1997;82(4):1220–1228
  56. Tiihonen J, Vilkman H, Rasanen P, Ryynanen OP, Hakko H, Bergman J, et al. Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography. Molecular Psychiatry. 1998;3(2):156–161
  57. Trulson ME, Jacobs BL. Raphe unit activity in freely moving cats: correlation with level of behavioral arousal. Brain Research. 1979;163(1):135–150
  58. Ursin R. Serotonin and sleep. Sleep Medicine Reviews. 2002;6(1):55–69
  59. Watkins KE, Paus T, Lerch JP, Zijdenbos A, Collins DL, Neelin P, et al. Structural asymmetries in the human brain: a voxel-based statistical analysis of 142 MRI scans. Cerebral Cortex. 2001;11(9):868–877
  60. Wichers M, Maes M. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. International Journal of Neuropsychopharmacology. 2002;5(4):375–388
  61. Wurtman JJ. Carbohydrate craving. Relationship between carbohydrate intake and disorders of mood. Drugs. 1990;39(Suppl. 3):49–52
  62. Wurtman JJ, Brzezinski A, Wurtman RJ, Laferrere B. Effect of nutrient intake on premenstrual depression. American Journal of Obstetrics and Gynecology. 1989;161(5):1228–1234
  63. Yamato T, Yamasaki S, Misumi Y, Kino M, Obata T, Aomine M. Modulation of the stress response by coffee: an in vivo microdialysis study of hippocampal serotonin and dopamine levels in rat. Neuroscience Letters. 2002;332(2):87–90
  64. Yonkers KA, Halbreich U, Freeman E, Brown C, Endicott J, Frank E, et al. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group. JAMA: The Journal of the American Medical Association. 1997;278(12):983–988

PII: S0925-4927(05)00215-5

doi: 10.1016/j.pscychresns.2005.02.012

Psychiatry Research: Neuroimaging
Volume 146, Issue 2 , Pages 107-116 , 31 March 2006

Article Tools

* Image Usage & Resolution